E 0471

Drug Profile

E 0471

Alternative Names: E 047/1; MW 436

Latest Information Update: 24 Apr 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ebewe
  • Class Antiarrhythmics; Benzofurans
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Ventricular arrhythmias

Most Recent Events

  • 24 Apr 2007 Discontinued - Phase-II for Ventricular arrhythmias in Austria (IV)
  • 13 Mar 2001 BASF's pharmaceutical business has been acquired by Abbott Laboratories
  • 17 Aug 2000 A clinical study has been added to the adverse events, pharmacokinetics and Arrhythmias pharmacodynamics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top